专题：Diabetes Treatment and Management

This cluster of papers focuses on the management of diabetes mellitus, with a particular emphasis on cardiovascular outcomes, glucose control, and the use of incretin hormones, SGLT2 inhibitors, and dipeptidyl peptidase-4 inhibitors. It also covers topics such as heart failure, glycemic control, insulin therapy, and clinical guidelines for the treatment of type 2 diabetes.
最新文献
Metabolic medicines and addiction: what GLP-1 receptor agonists might add to substance use care

article Full Text OpenAlex

Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study

article Full Text OpenAlex

Prospects of GLP-1 Therapies for Addiction and Mental Health Comorbidities—Quo Vadis?

article Full Text OpenAlex

Emerging incretin- and multi-agonist-based treatments – the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond

article Full Text OpenAlex

Clinical Trial: Semaglutide Versus Placebo in NIT ‐Assessed MASH —A Multicenter Randomised Placebo‐Controlled Trial ( SAMARA )

article Full Text OpenAlex

GLP-1 receptor agonists for secondary prevention after myocardial infarction and stroke in type 2 diabetes: nationwide real-world evidence

article Full Text OpenAlex

Ethical considerations for semaglutide use in children

article Full Text OpenAlex

Prevalence of use and interest in using glucagon-like peptide-1 receptor agonists for weight loss: a population study in Great Britain

article Full Text OpenAlex

The expanding landscape of GLP-1 medicines

article Full Text OpenAlex

Mechanisms and clinical implications of gut-brain interactions

article Full Text OpenAlex

近5年高被引文献
Tirzepatide Once Weekly for the Treatment of Obesity

article Full Text OpenAlex 2802 FWCI447.141

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

article Full Text OpenAlex 2449 FWCI320.1954

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

article Full Text OpenAlex 2214 FWCI451.0384

Empagliflozin in Patients with Chronic Kidney Disease

article Full Text OpenAlex 2177 FWCI284.1996

2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

article Full Text OpenAlex 1896 FWCI422.2167

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

article Full Text OpenAlex 1844 FWCI279.0748

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

review Full Text OpenAlex 1782 FWCI221.2767

2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes

article Full Text OpenAlex 1291 FWCI263.1567

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

article Full Text OpenAlex 1244 FWCI457.7448

KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

article Full Text OpenAlex 1107 FWCI142.5881